XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue:    
Total revenue $ 38,900 $ 33,173
Cost of Revenue:    
Amortization of intangible assets 183 183
Total cost of revenue 29,139 19,018
Gross profit 9,761 14,155
Operating Expense:    
Research and development 48,939 52,937
Sales, general and administrative 39,818 39,804
Change in the estimated fair value of contingent consideration 12,256 (1,063)
Total operating expense 101,013 91,678
Operating loss (91,252) (77,523)
Interest expense (3,630) (3,697)
Other income (expense), net 6,867 (279)
Loss before expense (benefit) from income taxes (88,015) (81,499)
Expense (benefit) from income taxes 0 0
Net loss (88,015) (81,499)
Other comprehensive income (loss):    
Unrealized gain (loss) on investments 2,841 (2,998)
Comprehensive loss $ (85,174) $ (84,497)
Net loss per share:    
Basic (in dollars per share) $ (0.36) $ (0.37)
Diluted (in dollars per share) $ (0.36) $ (0.37)
Weighted average shares outstanding used in calculating net loss per share:    
Basic (in shares) 242,032 222,289
Diluted (in shares) 242,032 222,289
Product revenue    
Revenue:    
Total revenue $ 34,654 $ 28,244
Cost of Revenue:    
Cost of revenue 25,164 14,820
Service and other revenue    
Revenue:    
Total revenue 4,246 4,929
Cost of Revenue:    
Cost of revenue $ 3,792 $ 4,015